Clinical trials
Osteosarcoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 10 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 5 |
| Blokhin's Russian Cancer Research Center | 2 |
| Grupo Espanol de Investigacion en Sarcomas | 2 |
| Ruijin Hospital | 2 |
| Shanghai Yunying Medical Technology | 2 |
| Sun Yat-sen University | 2 |
| Tata Memorial Hospital | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| AlaMab Therapeutics (Shanghai) Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteosarcoma | 57 |
| Sarcoma | 13 |
| Sarcoma, Ewing | 8 |
| Bone Neoplasms | 7 |
| Chondrosarcoma | 5 |
| Neuroblastoma | 4 |
| Rhabdomyosarcoma | 3 |
| Chordoma | 2 |
| Disease Progression | 2 |
| Drug-Related Side Effects and Adverse Reactions | 2 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.